Research on a disease outbreak highlights the need for effective treatment and prevention for young children. A significant proportion of children under five who were diagnosed with the disease have died. Barriers to accessing medical help include delayed trial inclusion and safety concerns.

An ongoing study started in mid-July to evaluate an oral antiviral for preventing infection after high-risk exposure. This study aims to address the need for effective prevention measures. Further details on the outbreak and research efforts are available from the source.